Exhibit 10.1

 

RELMADA THERAPEUTICS, INC.

 

NOTE AND WARRANT PURCHASE AGREEMENT

 

THIS NOTE AND WARRANT PURCHASE AGREEMENT (the “Purchase Agreement”), dated this
__ day of __________ 2017, is by and between ___________, (the “Buyer”), and
RELMADA, THERAPEUTICS, INC., a Nevada corporation (the “Company”).

 

WHEREAS, the Buyer wishes to purchase from the Company and the Company wishes to
sell to the Buyer, upon the terms and subject to the conditions of this Purchase
Agreement, a convertible promissory note of the Company, in the principal amount
of $.

 

NOW THEREFORE, in consideration of the premises and the mutual covenants
contained herein and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties agree as follows:

 

1. Sale and Issuance of Note and Warrant. Upon the terms and subject to the
conditions of this Purchase Agreement, the Buyer agrees to purchase from the
Company, and the Company agrees to sell and issue to the Buyer, a convertible
subordinated promissory note, in the form attached hereto as Exhibit A (the
“Note”), in the principal amount of $____________(the “Principal Sum”), subject
to the terms and conditions of the Note. In order to induce the Buyer to
purchase the Note, the Company will deliver a warrant, in the form attached
hereto as Exhibit B (the “Warrant”), to the Buyer to purchase, subject to the
terms and conditions of the Warrant, in whole or in part, up to that number of
fully paid, validly issued and nonassessable shares of Company’s common stock
(the “Common Stock”). Each Warrant will entitle such Investor to purchase up to
that number of shares of Common Stock equal to (a) fifty percent (50%) of the
Principal Sum purchased by such Investor divided by (b) $0.75. The exercise
price per share for the Warrant shall be $1.50.

 

2. Representations and Warranties of the Company. By executing this Purchase
Agreement, the Company makes the following representations and, warranties to
the Buyer, with the intent and understanding that the Buyer will rely thereon:

 

2.1 Organization of the Company; Authorization; Good Standing. The Company is a
corporation duly organized, validly existing and in good standing under the laws
of the State of Nevada and has all requisite corporate power and authority to
own and lease its property, to carry on its business as presently conducted and
as proposed to be conducted (as previously disclosed to the Buyer) and to
execute and deliver, and to perform all of its obligations under, this Purchase
Agreement, the Note and the Warrant (collectively, the “Company Documents”).

 

2.2 Enforceability. The creation and issue of the Note and the execution and
delivery by the Company of the Company Documents and the consummation of the
transactions contemplated thereby have been duly authorized by all requisite
corporate action on the part of the Company, and the Company Documents have been
duly executed and delivered by the Company and constitutes the legal, valid and
binding obligation of the Company, enforceable in accordance with its terms.

 

2.3 Complete and Accurate Information. All information provided by the Company
in whatever form in connection with the transactions contemplated by the Company
Documents are complete and accurate and provide a true and fair view of the
financial position of the Company.

 

  

 

 

3. Representations and Warranties of the Buyer. By executing this Purchase
Agreement, the Buyer makes the following representations and warranties to the
Company, with the intent and understanding that the Company will rely thereon:

 

3.1 Investment Representations. The Buyer has knowledge and experience in
financial and business matters sufficient to enable him to evaluate the merits
and risks of an investment in the Note, the shares of the Company’s Common stock
issuable upon conversion of the Note (the “Shares”) and the Company. The Buyer
has assets sufficient to enable him to bear the economic risk of the Buyer’s
investment in the Note. The Buyer is acquiring the Note for investment purposes
only, for his, her or its own account, and not with a present view to, or for
sale in connection with, any distribution thereof. The Buyer understands that
the Note and the Shares have not been registered under the Securities Act by
reason of their issuance in a transaction exempt from the registration
requirements of the Securities Act pursuant to the exemption provided in Section
4(2) thereof, that the Note and the Shares have not been registered under
applicable state securities laws by reason of their issuance in a transaction
exempt from such registration requirements, and that the Note and the Shares may
not be sold or otherwise disposed of unless registered under the Securities Act
and applicable state securities laws (the Company being under no obligation to
register such Note or the Shares) or exempted from registration. The Buyer
further acknowledges that the Note and the Shares are subject to the
restrictions on transfers set forth in the Company Documents, and that each
transferee of the Note or the Shares as a condition to such transfer may be
required to agree in writing to be bound by such restrictions.

 

3.2 Buyer’s Acknowledgment as to Information. The Buyer or representatives of
the Buyer have received from the Company such information (including exhibits to
this Purchase Agreement and of such documents referred to herein and therein as
he or they have requested) with respect to the Company as the Buyer has deemed
necessary and relevant in connection with the transactions contemplated by the
Company Documents, and the Buyer has had the opportunity, directly or through
such representatives, to ask questions of and receive answers from persons
acting on behalf of the Company necessary to verify the information so obtained.

 

3. Legend. Each certificate evidencing the Note and the Company’s securities
issuable upon conversion of the Note, and each certificate evidencing the Note
and the Company’s securities issuable upon conversion of the Note held by
subsequent transferees of any such certificate, shall be stamped or otherwise
imprinted with a legend in substantially the following form:

 

"THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933. THE SHARES MAY NOT BE SOLD OR OFFERED FOR SALE IN THE ABSENCE OF
(A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SHARES UNDER SUCH ACT, (B) A "NO
ACTION" LETTER OF THE SECURITIES AND EXCHANGE COMMISSION WITH RESPECT TO SUCH
SALE OR OFFER OR (C) SATISFACTORY ASSURANCES TO THE CORPORATION THAT
REGISTRATION UNDER SUCH ACT IS NOT REQUIRED WITH RESPECT TO SUCH SALE OR OFFER."

 

 2 

 

 

4. Miscellaneous.

 

4.1 Legal Fees and Expenses. Each party hereto agrees to pay its own legal fees
and expenses incurred in connection with the transactions contemplated
hereunder.

 

4.2 No Waiver. The failure of a party to insist upon strict adherence to any
term of this Purchase Agreement on any occasion shall not be considered a waiver
or deprive that party of the right thereafter to insist upon strict adherence to
that term or any other term of this Purchase Agreement. Any waiver of any term
of this Purchase Agreement must be in writing.

 

4.3 Entire Agreement; Amendment. This Purchase Agreement and all Exhibits
hereto, set forth the entire agreement of the parties with respect to the
subject matter hereof and supersede all prior agreements relating thereto,
written or oral. This Purchase Agreement may be amended or modified only by a
written instrument executed by the Company and the Buyer.

 

4.4 Parties in Interest; Limitation on Assignment. This Purchase Agreement shall
inure to the benefit of and be binding upon the parties and their respective
permitted successors and assigns.

 

4.5 Counterparts. This Purchase Agreement may be executed in any number of
counterparts, each of which shall be considered an original, but all of which
together shall constitute one and the same instrument.

 

4.6 Governing Law. This Purchase Agreement shall be governed by, construed,
interpreted and enforced in accordance with the laws of the State of New York as
applied to contracts entered into and performed entirely within the State of New
York without regard to conflicts of laws principles.

 

4.7 Notices. All notices, consents and other communications under this Purchase
Agreement shall be in writing and shall be deemed to have been duly given when
(a) delivered by hand, (b) sent by telex or telecopier (with receipt confirmed),
provided that a copy is mailed by registered mail, return receipt requested, or
(c) when received by the addressee, if sent by Express Mail, Federal Express or
other express delivery service (receipt requested), in each case to the
appropriate addresses, telex numbers and telecopier numbers set forth below (or
to such other addresses, telex numbers and telecopier numbers as a party may
designate as to itself by notice to the other party):

 

4.7.1 If to the Company:

 

RELMADA THERAPEUTICS, INC.

750 Third Avenue, 9th floor

New York, NY 10017

Attention: Sergio Traversa, PharmD.

Chief Executive Officer

 

 3 

 

 

4.7.2 If to the Buyer:

 

 

 

 

4.8 Severability. In the event that any court having jurisdiction shall
determine that any provision contained in this Purchase Agreement shall be
unreasonable or unenforceable in any respect, then such covenant or other
provision shall be deemed limited to the extent that such court deems it
reasonable and enforceable, and as so limited shall remain in full force and
effect. In the event that such court shall deem any such covenant or other
provision wholly unenforceable, the remaining covenants and other provisions of
this Purchase Agreement shall nevertheless remain in full force and effect.

 

4.9 Headings and Captions. The headings and captions used herein to identify
sections and subsections are for convenience only and shall not be used for
interpretation of any provisions herein.

 

4.10 Indemnity. The representations, warranties and agreements made by the
Company and the Buyer herein shall survive the execution of this Purchase
Agreement. The Company and the Buyer hereby agree to indemnify and hold harmless
the other party from and against any and all loss, liability, claim, damage and
expense (including, without limitation, attorneys’ fees and disbursements)
suffered or incurred as a result of a misrepresentation or breach of any
warranty or agreement made by the defaulting party in this Purchase Agreement.

 

[Signature Page Follows]

 

 4 

 

 

IN WITNESS WHEREOF, each of the parties has caused this Purchase Agreement to be
executed on its behalf with the intent to be legally bound as of the day and
year first above written.

 

      RELMADA THERAPEUTICS, INC.               By:                  Name: Sergio
Traversa, PharmD       Title: Chief Executive Officer           BUYER:          
                  Name:         Title:        

 

  

 

 

EXHIBIT A

 

FORM OF CONVERTIBLE PROMISSORY NOTE

 

(see attached)